Posted in M&A / Deals Cumberland to sell drug portfolio to Apotex for $100m April 24, 2026 Pharmaceutical Technology Cumberland Pharmaceuticals has agreed to sell its branded commercial drug portfolio to Canada-based Apotex for $100m in cash. M&A / DealsRead full story